SEC Form 4 · accession 0001093557-16-000592
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Lister
Officer — General Manager, EMEA
Period of report
Jun 30, 2016
Accepted (ET)
Jul 5, 2016 · 8:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 30, 2016 | A | 32,000 | $0.001 | A | 97,894 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 33 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 21 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
- F2Included in this number are 78,667 unvested restricted stock units, 32,000 of which were grant on June 30, 2016 and shall vest through March 8, 2019, 25,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 21,667 of which were granted on March 8, 2014 and shall vest through March 8, 2017.